Mycoplasma gallisepticum conjunctivitis emerged in 1994 as a disease of free-ranging House Finches (Carpodacus mexicanus) in North America and has also been isolated from other songbirds with conjunctivitis. A key feature for the successful study of natural and experimental disease has been the apparent, very-high correlation between characteristic eye lesions and M. gallisepticum. Mycoplasma sturni was originally isolated from an adult European Starling (Sturnus vulgaris) with bilateral conjunctivitis and has since been reported in a relatively small number of other avian species, but not in House Finches. We identified as M. sturni a mycoplasma isolate from a California House Finch with conjunctivitis. However, experimental infection of House Finches with the M. sturni isolate failed to reproduce the disease. Therefore, M. gallisepticum remains the primary known cause of conjunctivitis in House Finches.
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Mycoplasma gallisepticum conjunctivitis emerged in 1994 as a disease of freeranging House Finches (Carpodacus mexicanus) in the mid-Atlantic region of the United States and has since spread to House Finches throughout their entire eastern range (Ley et al., 1996; Luttrell et al., 1996; Ley et al., 1997; Dhondt et al., 1998; Hartup et al., 2001a,b) . The resulting epidemic of M. gallisepticum conjunctivitis produced an unprecedented decline in eastern House Finch populations, and the endemic disease remains associated with repeating, seasonal peaks of conjunctivitis and the limitation of host populations (Hochachka and Dhondt, 2000; Altizer et al., 2004) . Mycoplasma gallisepticum has also been isolated from other songbirds with conjunctivitis, notably American Goldfinch (Carduelis tristis), Purple Finch (Carpodacus purpureus), Evening Grosbeak (Coccothraustes vespertinus) and Pine Grosbeak (Pinicola enucleator) (Fischer et al., 1997; Ley et al., 1997; Hartup et al., 2000; Mikaelian et al., 2001) . Because conjunctivitis in House Finches has been monitored and sampled extensively, it has become a model system for understanding emerging infectious diseases in wild avian hosts (Dhondt et al., 1998; Hartup et al., 2001a, b; Dhondt et al., 2005 Dhondt et al., , 2006 . A key feature for the successful study of natural and experimental disease has been the apparent, very-high correlation between characteristic eye lesions and M. gallisepticum. Mycoplasmas isolated from all known susceptible host species had always been identified as M. gallisepticum, resulting in the assumption, used for both field and experimental observations, that characteristic eye lesions in susceptible host species were evidence of M. gallisepticum infection.
The original isolate and type strain (UCMF5ATCC 51945) of M. sturni was from an adult European Starling (Sturnus vulgaris) with bilateral conjunctivitis in Connecticut, USA (Forsyth et al., 1996; Frasca et al., 1997) . Subsequently, M. sturni was isolated from Northern Mockingbirds (Mimus polyglottos) and Blue Jays (Cyanocitta cristata) in Florida, USA, with clinical signs and gross lesions suggestive of M. gallisepticum conjunctivitis in House Finches (Ley et al., 1998) . In Minnesota, USA, M. sturni was isolated from an American Crow (Corvus brachyrhynchos) with conjunctivitis and in asymptomatic American Crows caged with a nest-mate of the crow with conjunctivitis (Wellehan et al., 2001) . Mycoplasma sturni was also found in asymptomatic American Robins (Turdus migratorius) and European Starlings housed at the same facility as the crows. The authors concluded that M. sturni can infect American Crows and American Robins, with or without the presence of clinical disease (Wellehan et al., 2001) . Postmortem sampling of wild birds in Scotland found M. sturni in 18 of 41 birds tested; all birds were immature and included Blackbird (Turdus merula), Rook (Corvus frugilegus), Carrion Crow (Corvus corone), Magpie (Pica pica), and European Starling (Pennycott et al., 2005) .
Herein, we report the isolation of M. sturni from a House Finch with conjunctivitis. However, experimental infection of House Finches with the M. sturni isolate failed to reproduce the disease.
Twelve juvenile House Finches were admitted to the Lindsay Wildlife Museum (LWM; Walnut Creek, California, USA) on 2 and 3 May 2006. All 12 House Finches were apparently normal, with no noted eye lesions, so they were transported to two separate home-care rehabilitation facilities on 3 May 2006. Prior to, and during, transport birds were housed in small, plastic enclosures each containing 2-4 birds. Initially, House Finches 1166 Finches , 1167 Finches , 1168 Finches , 1169 Finches , 1170 Finches , 1177 , and 1200 went to site A where they were housed in one enclosure. Birds 1196, 1197, 1198, and 1199 went to site B where they were housed in one enclosure. On 12 May, two House Finches (1177, 1200) were transferred from site A to site B and housed with birds 1196-1199. Between 12 May and 18 May, three of the five finches remaining at site A (1167, 1169, 1170) developed conjunctivitis. During this time, three House Finches at site A died (1166, 1168, 1169) , and two were euthanized due to the development of conjunctivitis (1167, 1170) . No diagnostics were performed on this group of birds.
On 18 May, House Finches 1177 and 1200, which had been transferred to site B, were presented to the LWM hospital with eye lesions compatible with M. gallisepticum conjunctivitis and euthanized without diagnostics. On 23 May, House Finch 1197 died with no specific clinical signs. The next day, House Finches 1196, 1198, and 1199 were returned to the LWM hospital because bird 1196 had conjunctivitis of the right eye. The eyes of all three birds were examined grossly and all were given eye lesion scores of 0 (normal), except for the right eye of bird 1196, with an eye lesion score of 2 on a scale of 0-3 . Swabs of conjunctivae (left and right eye swabs pooled to one tube of Frey's mycoplasma broth [Kleven, 2008] with 15% swine serum [FMS] ) and choanal clefts from each of these three birds were taken as previously described and shipped to North Carolina State University College of Veterinary Medicine (NCSU CVM; Raleigh, North Carolina, USA) for mycoplasma culture and M. gallisepticum polymerase chain reaction (PCR). Three pooled conjunctival samples and three choanal cleft samples from these birds were negative for M. gallisepticum by mgc2 PCR (Hong et al., 2005) and no mycoplasmas were isolated from cultures. All three birds were euthanized by CO 2 inhalation and whole carcasses submitted to the California Animal Health and Food Safety (CAHFS) Laboratory System (Davis, California, USA).
Of the three House Finches (1196, 1198, 1199) submitted to CAHFS for necropsy and diagnostic testing, bird 1196 had the most severe physical signs of conjunctivitis and the spleen was soft and appeared enlarged. Microscopic lesions consisted of mild to moderate pleocellular infiltrates of the conjunctiva with perivascular and nodular lymphoid aggregates. There were small bacteria on the conjunctival epithelium. On the eyelids, there was a moderate hyperkeratosis with multifocal intracorneal pustules with cellular debris. Air sacs had scattered mild infiltrates of lymphocytes and plasmocytes. The results were summarized as 1) conjunctivitis, pleocellular with lymphoid aggregate, moderate, and 2) airsacculitis, mononuclear, multifocal, mild. There was no evidence of trichomoniasis or poxvirus, and tests for chlamydia, avian influenza, exotic Newcastle disease, and West Nile virus were negative. Toxicology-heavy metal screen showed only nontoxic concentrations, aerobic bacterial cultures of lung and liver showed no growth, and no Salmonella spp. were detected from intestinal contents. Conjunctival swabs were cultured for mycoplasmas. Findings were similar for House Finch 1198, summarized as 1) conjunctivitis, pleocellular, mild, and 2) sinusitis, pleocellular with foreign material and intraluminal parasite, mild, focal; and for finch 1199, which also had conjunctivitis and tracheitis, but no sinusitis.
A Mycoplasma sp. isolate was made from House Finch 1198 but not from the other two birds. The CAHFS used species-specific antibody conjugates to M. gallisepticum, M. synoviae, M. meleagridis, and M. iowae, all of which did not react. We contacted CAHFS and requested a sample of the mycoplasma isolate and, on 27 June 2006, received two broth samples (Frey's and ORT media) and one divided agar plate (Frey's and ORT media) with isolates from House Finch 1198. Mycoplasma gallisepticum PCR tests using primers (Hong et al., 2005) to the mgc2 surface protein gene on samples from the two broth cultures were negative. However, sub-passages to FMS resulted in mycoplasmal growth, and further passage to FMS agar resulted in mycoplasma colonies that were identified as M. sturni by indirect immunofluorescence (Ley et al., 1998) using M. sturni rabbit antiserum (Forsyth et al., 1996) provided by S. Geary (Center of Excellence for Vaccine Research, Department of Pathobiology & Veterinary Science, University of Connecticut, Storrs, Connecticut, USA). Mycoplasma colonies on agar were also tested by direct immunofluorescence (Kleven, 2008) using fluorescein-conjugated rabbit M. gallisepticum antiserum provided by S. H. Kleven (College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA), which did not react. Therefore, only M. sturni was isolated from House Finch 1198, which presented originally with normal eyes but, later and at necropsy, with mildly swollen eyelids and mild pleocellular nonspecific conjunctivitis.
To assess the pathogenic potential of M. sturni in House Finches, we conducted a challenge study using an inoculum (2006.054-2 2P) prepared from the bird 1198 isolate. All procedures and protocols were reviewed by the Cornell University Institutional Animal Care and Use Committee (Protocol 00-90).
Ten, wild-caught, hatch-year (Gustafson et al., 1997) House Finches were captured using mist nets in Tompkins County, New York, USA (42u519N, 76u349W) during May-September 2007 under a permit from the New York State Department of Environmental Conservation (Albany, New York, USA, permit LCP 99-039) and a federal collecting permit (PRT 802829). The House Finches were housed in quarantine for 2-3 wk, during which they were examined for eye lesions and blood, conjunctival (left and right eye combined), and choanal cleft swabs were collected. Plasma was tested for M. gallisepticum antibodies by rapid plate agglutination (RPA; Kleven, 2008) using MG Nobilis Antigen (Intervet Inc., Millsboro, Delaware, USA), and the swabs were tested for M. gallisepticum by PCR (Lauerman, 1998) . There was no evidence of conjunctivitis or M. gallisepticum infection. Birds were housed in individual wire bar cages (45 cm high 3 45 cm wide 3 75 cm long) with sheet-metal barriers around and between cages to prevent airborne or particle transmission between cages. Water and commercial pelleted diet (Roudy-bush, Inc. Cameron Park, California, USA) were provided ad libitum. The cages were in a biosafety level-2 isolation facility at the College of Veterinary Medicine, Cornell University (Ithaca, New York, USA).
Six days before inoculation, blood, conjunctival (left and right eye combined), and choanal cleft swabs of all 10 House Finches were collected. Plasma was collected for M. gallisepticum serology by RPA, and the swabs were used to inoculate FMS broths for mycoplasma culture. On 30 October 2007, nine House Finches were inoculated bilaterally in the palpebral conjunctiva with 0.05 ml of M. sturni inoculum 2006.054-2 2P containing 1.148310 7 color changing units/ml (viable count determined by most probable number method). One House Finch (shaminoculated negative control) was inoculated with sterile physiologic saline (without preservative). The conjunctival sacs (left and right eye combined) and choanal cleft of each House Finch were swabbed on days 7, 14, 21, 27, and 35 postinoculation (PI). On day 2 PI, only conjunctival swabs were taken. Samples were collected using wooden, cotton-tipped swabs (14-960-78, Fisher Scientific, Pittsburgh, Pennsylvania, USA) and immediately transferred to FMS broth. The swabs were removed and the inoculated FMS broths were incubated at 37 C until color changed, or for up to 1 wk. They were then frozen and maintained at 270 C until the trial was completed, then shipped overnight on dry ice to NCSU CVM. Two samples of the M. sturni inoculum used were also frozen and returned to NCSU CVM for confirmation of viability and identification. At NCSU CVM, samples were thawed at room temperature, then 400 ml were transferred to 2 ml FMS broth and incubated at 37 C for mycoplasma culture. Incubating broths were observed daily for color change suggestive of mycoplasmal growth, at which time transfers were made to FMS agar. Mycoplasmal colonies on agar were identified as M. sturni as described above. The two samples of inoculum were successfully grown in culture and identified as M. sturni by indirect immunofluorescence and negative for M. gallisepticum by direct immunofluorescence. This confirmed that the inoculum used was viable and contained only M. sturni. All but two pre-and postinoculation samples were negative for mycoplasmal growth in culture. One conjunctival sample from an inoculated House Finch taken on day 27 PI was discarded due to contaminant overgrowth. One conjunctival sample from an inoculated House Finch, taken on day 2 PI, was culture positive for mycoplasmas identified as M. sturni by indirect immunofluorescence.
Each House Finch was evaluated for gross eye lesions, using the scoring system previously described , on days 2, 6, 7, 14, 21, 27, and 35 PI. Eye lesion scores were 0 (normal) for each bird at each observation, so there was no gross evidence of conjunctivitis. Furthermore, there was no morbidity or mortality, indicating that these House Finches remained clinically normal and healthy. Additionally, birds were weighed before and after inoculation on a weekly basis with no changes noted.
Blood was collected from the left wing vein into two lithium-heparinized microcapillary tubes for detection of M. gallisepticum antibody using RPA (Kleven, 2008) on days 14, 21, and 35 PI. All preand postinoculation samples were negative by RPA for M. gallisepticum antibodies.
M. gallisepticum and M. sturni have been identified in relatively limited numbers of different wild avian hosts, a demonstration that natural infections with each of these tend to be somewhat limited in host-species range. This is the first report of M. sturni isolated from a House Finch with conjunctivitis. This new finding is significant because it could confound and complicate the evolving understanding of the ongoing epidemic of M. gallisepticum conjunctivitis in House Finches and in some similar host species. Therefore, we felt that it was important to determine the infection and pathogenic potentials of the M. sturni isolate in House Finches and that this could be accomplished most directly by experimental challenge. We used a challenge model similar to one that we have used successfully, many times, with M. gallisepticum and House Finches, with a challenge dose that was approximately one log higher. Conjunctival inoculation of House Finches with the M. sturni isolate resulted in transient evidence of infection in one of nine birds and no evidence of disease. Currently, isolation of M. sturni from a House Finch is a unique event. Of 91 Mycoplasma spp. isolates made from wild House Finches since 1998, 87 were M. gallisepticum, three were unidentified (but not M. gallisepticum or M. sturni), and one was M. sturni. In this particular case, one must consider the possibility that M. sturni was the sole or primary cause of disease, but co-infection with M. gallisepticum or some other causes of conjunctivitis cannot be ruled out. Nonmycoplasmal causes of conjunctivitis in passerines include Thelazia analabiata (Elias et al., 2008) , herpesvirus (Mueller, 1990; Paulman et al., 2006) , avipoxvirus (Hukkanen et al., 2003) , paramyxovirus (Schemera et al., 1987) , and toxoplasmosis (Vickers et al., 1992) . Host and environmental factors may also play important roles in infection and disease, and stress or co-infections (polymicrobial disease) may result in different outcomes (Lindstrom et al., 2005) .
The chain of evidence in this case was complex, and the possibility of error or 'contamination' cannot be completely discounted, nor can the possibility of isolate misidentification. In any case, based on the uniqueness of this occurrence and the failure to reproduce conjunctivitis following experimental infection, it is reasonable to conclude that M. 
